CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Synovics Pharmaceuticals Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Synovics Pharmaceuticals Inc
5360 NW 35th Ave
Phone: (954) 486-4590p:954 486-4590 FORT LAUDERDALE, FL  33309-6314  United States Ticker: SYVCSYVC
This company ceased filing statements with the SEC on 12/11/2009.
Business Summary
Synovics Pharmaceuticals, Inc. (Synovics) is a specialty pharmaceutical company engaged in the development, manufacturing and commercialization of generic over the counter (OTC) pharmaceutical products and generic prescription drug products. The Company is a manufacturer, packager and distributor of private label, or store brand, OTC products to chain drug stores, wholesalers and distributors throughout the United States. The Company’s OTC product categories include analgesics, cough and cold, antihistamines, asthma relief and laxatives. The Company has two primary subsidiaries, Kirk Pharmaceuticals, LLC (Kirk), and ANDAPharm, LLC (ANDAPharm). Kirk manufactures and distributes OTC products developed by or licensed to the Company. ANDAPharm serves as the product research and RX manufacturing arm of the Company with a focus on the development of active compounds for drugs.
(Source: 10-K)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
7/31/200910/31/2008YesYesYes-Yes

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Secretary Ronald H.Lane 7/3/2008 12/1/1994
Interim Principal Executive Officer, Director JyotindraGange 64 7/3/2008 5/1/2008
Chief Financial Officer MahendraDesai 65 10/6/2008 10/6/2008
4 additional Officers and Directors records available in full report.

Business Names
Business Name
Andapharm LLC
Bionutrics Health Products, Inc.
Cosmedics, Inc.
7 additional Business Names available in full report.

General Information
Number of Employees: 155 (As of 10/31/2008)
Outstanding Shares: 30,448,162 (As of 9/15/2009)
Shareholders: 223
Stock Exchange: OTC
Federal Tax Id: 860760991
Email Address: mwinfo@morgen-walke.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, August 28, 2023